These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 7822809

  • 21. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC, Frazier B, Ley TJ, Holers VM.
    J Immunol; 1989 Aug 01; 143(3):923-30. PubMed ID: 2473114
    [Abstract] [Full Text] [Related]

  • 22. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun 01; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Infection of human thymocytes by Epstein-Barr virus.
    Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, Tsoukas CD.
    J Exp Med; 1991 Apr 01; 173(4):971-80. PubMed ID: 1706754
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G, Magrath IT, Blaese RM.
    J Immunol; 1982 Feb 01; 128(2):575-9. PubMed ID: 6274959
    [Abstract] [Full Text] [Related]

  • 33. B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV).
    Hu CP, Aman P, Masucci MG, Klein E, Klein G.
    Eur J Immunol; 1986 Jul 01; 16(7):841-5. PubMed ID: 3013647
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T, Sato H, Ogura H, Miyawaki T, Glaser R.
    Cancer Res; 1986 May 01; 46(5):2541-4. PubMed ID: 3008992
    [Abstract] [Full Text] [Related]

  • 37. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies.
    Tsoukas CD, Lambris JD.
    Eur J Immunol; 1988 Aug 01; 18(8):1299-302. PubMed ID: 2970972
    [Abstract] [Full Text] [Related]

  • 38. Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes.
    Fischer EM, Mouhoub A, Maillet F, Frémeaux-Bacchi V, Krief C, Gould H, Berrih-Aknin S, Kazatchkine MD.
    Int Immunol; 1999 Nov 01; 11(11):1841-9. PubMed ID: 10545488
    [Abstract] [Full Text] [Related]

  • 39. Infection of normal human thymic epithelial cells by Epstein-Barr virus (EBV) following implantation of EBV receptors.
    Seshi B, Volsky B, Anderson RW, Purtilo DT, Volsky DJ.
    Thymus; 1984 Nov 01; 6(1-2):5-13. PubMed ID: 6087504
    [Abstract] [Full Text] [Related]

  • 40. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.
    Cantaloube JF, Piechaczyk M, Calender A, Lenoir G, Minty A, Carrière D, Fischer E, Poncelet P.
    Eur J Immunol; 1990 Feb 01; 20(2):409-16. PubMed ID: 1690137
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.